← Back to patent-cliff list
CAS 13734-41-3
(S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid
Codes: (I)692039-1-a
Application context (from source-drug indications)
冠状病毒感染TRV-120027COVID-19TRV-120027Acute decompensated heart failureTRV-120027Kidney diseaseTRV-120027Heart failureTRV-120027
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| TRV-120027 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid→Ethoxycarbonyl N-(tert-butoxycarbonyl)-L-valinate→(-)-alpha-Amino-p-hydroxyhydrocinnamic acid→N-(tert-Butoxycarbonyl)-L-valyl-L-tyrosine→Ethoxycarbonyl N-(tert-butoxycarbonyl)-L-valyl-L-tyrosinate→(2S,3S)-alpha-Amino-beta-merthylvaleric acid→N-(tert-Butoxycarbonyl)-L-valyl-L-tyrosyl-L-isoleucine→Benzyl L-histidyl-L-prolyl-D-alaninate hydrochloride→Benzyl L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alaninate hydrochloride→N-[(Benzyloxy)carbonyl]-N-methylglycyl-L-arginine→Benzyl N-[(benzyloxy)carbonyl]-N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alaninate hydrochloride→N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alanine acetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.